Abivax S.A. (0RA9.L) LSE

120.80

+1.2(+1.00%)

Updated at December 24 12:37PM

Currency In EUR

Valuation

Market Cap426.19M
Enterprise Value379.33M
P/E Ratio-39.59
PEG Ratio3.82
Price/Sales Ratio1,578.54
Price/Book Ratio-160.23
Enterprise/Revenue1,584.81
Enterprise/EBITDA-51.47

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-32.44
Operating Margin-33.06

Management Effectiveness

Return On Assets-1.63
Return On Equity50.78

Income Statement

Revenue10.79M
Revenue/Share0.09
Gross Profit10.79M
EBITDA-167.68M
Net Income-176.24M
Diluted EPS-2.8

Balance Sheet

Total Cash60.95M
Total Cash/Share0.96
Total Debt98.71M
Total Debt/Equity-2.04
Current Ratio0.77
Book Value Per Share-0.76

Price History

52-Week Change1,623.25
52-Week High120.8
52-Week Low5.68
Moving Average 50 Days11.44
Moving Average 200 Days13.25

Statistics

Average Volume5,413
Shares Outstanding77.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A